New methodological approaches were able to effectively reduce immeasurable time bias in case-only designs.


Journal

Journal of clinical epidemiology
ISSN: 1878-5921
Titre abrégé: J Clin Epidemiol
Pays: United States
ID NLM: 8801383

Informations de publication

Date de publication:
03 2021
Historique:
received: 21 07 2020
revised: 29 10 2020
accepted: 03 11 2020
pubmed: 11 11 2020
medline: 22 9 2021
entrez: 10 11 2020
Statut: ppublish

Résumé

The objective of this study was to assess approaches to reduce immeasurable time bias in case-crossover (CCO), case-time-control (CTC), and case-case-time-control (CCTC) designs. We used Korea's health care database that has inpatient and outpatient prescriptions and an empirical example of benzodiazepines and mortality among the elderly. We defined our unbiased exposure setting using all prescriptions and a pseudo-outpatient setting using outpatient records only. In the pseudo-outpatient setting, we assessed 10 approaches of restricting, adjusting, stratifying, or weighting on hospitalization-related factors. We conducted conditional logistic regression to estimate odds ratio (OR) with 95% confidence intervals (CI), where an approach was considered effective when its OR was within the unbiased exposure setting OR's 95% CI. Immeasurable time bias negatively biased the unbiased exposure setting's OR in all three case-only designs, overestimating the protective effect of benzodiazepines on mortality. Of the 10 approaches examined, stratifying the proportion of hospitalized time in 0.01 intervals most effectively repaired the bias in the CCO (OR 1.25, 95% CI 1.10-1.43) and CTC analyses (1.11, 0.95-1.30); no approach was effective in the CCTC analysis. Stratifying the proportion of hospitalized time in 0.01 intervals best approximated the unbiased exposure setting estimate by overcoming the significant impact of immeasurable time bias in CCO and CTC designs.

Identifiants

pubmed: 33171274
pii: S0895-4356(20)31173-2
doi: 10.1016/j.jclinepi.2020.11.004
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-10

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Han Eol Jeong (HE)

School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, South Korea.

In-Sun Oh (IS)

School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, South Korea.

Hyesung Lee (H)

School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, South Korea.

Kristian B Filion (KB)

Department of Medicine, McGill University, Montreal, Quebec, Canada; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada; Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada.

Ju-Young Shin (JY)

School of Pharmacy, Sungkyunkwan University, Suwon, Gyeonggi-do, South Korea; Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul, South Korea. Electronic address: shin.jy@skku.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH